(Q58389083)

English

A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215

scientific article published on 01 December 2000

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090748%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090748%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Stefano Rusconi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090748%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

La Seta Catamancio S

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090748%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sheridan F

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090748%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Parker D

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090748%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 December 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090748%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Journal of Clinical Virology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090748%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090748%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090748%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

135-142

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090748%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Factors influencing the emergence of resistance to indinavir: role of virologic, immunologic, and pharmacologic variables.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900087-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900087-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900087-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900087-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900087-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Dual resistance to zidovudine and lamivudine in patients treated with zidovudine-lamivudine combination therapy: association with therapy failure

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900087-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900087-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI Group

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900087-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of line probe assay (LIPA) and sequence analysis for detection of HIV-1 drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900087-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinica

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900087-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy. Wellcome Resistance Study Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900087-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug resistance and heterogeneous long-term virologic responses of human immunodeficiency virus type 1-infected subjects to zidovudine and didanosine combination therapy. The AIDS Clinical Trials Group 143 Virology Team

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900087-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900087-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900087-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900087-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1386-6532(00)00087-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090748%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090748%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58389083&oldid=1910644823"